Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose metformin added to yoghurt in overweight adults with insulin resistance
NL-OMON36139Phase 4Active, not recruiting
- Sponsor
- Bouter
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of metformin in insulin resistance (IR), sponsored by Bouter. Primary endpoint: HbA1c. Started May 2011; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NL-OMON36139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36139.